Schalch D S, Gonzalez-Barcena D, Kastin A J, Landa L, Lee L A, Zamora M T, Schally A V
J Clin Endocrinol Metab. 1975 Nov;41(5):921-5. doi: 10.1210/jcem-41-5-921.
The pituitary gonadotropin response to the administration of synthetic LH-releasing hormone (LH RH) in 10 patients with renal failure and 5 patients with hepatic insufficiency was determined. The basal plasma LH and FSH levels were either normal or slightly elevated in both groups compared with the controls, but after the administration of LHRH, the peak levels (mean +/- SE mIU/ml) of LH (72.0 +/- 16.6) and FSH (18.7 +/- 4.4) in the patients with renal failure, and of LH (61.5 +/- 20.8) and FSH (13.2 +/- 2.8) in patients with hepatic insufficiency, were not significantly different from those in 11 normal controls (LH, 75.6 +/- 12.0; FSH, 12.4 +/- 2.9). However, significant elevations in plasma gonadotropin levels persisted in these patients during the second and third hours after the administration of LHRH. These studies do not resolve the question of whether the prolonged elevation in plasma LH and FSH levels after LHRH administration is due to enhanced secretion, to a diminished rate of metabolic clearance of LHRH, and/or to the gonadotropins, or both. Evidence from this and previous studies suggests that there may be defects in the secretory functions of both the hypothalamus and pituitary gland in some of these patients.
测定了10例肾衰竭患者和5例肝功能不全患者垂体促性腺激素对合成促黄体生成素释放激素(LH-RH)给药的反应。与对照组相比,两组患者的基础血浆LH和FSH水平均正常或略有升高,但给予LHRH后,肾衰竭患者的LH峰值水平(平均±标准误,mIU/ml)为(72.0±16.6),FSH为(18.7±4.4);肝功能不全患者的LH峰值水平为(61.5±20.8),FSH为(13.2±2.8),与11例正常对照者(LH,75.6±12.0;FSH,12.4±2.9)相比无显著差异。然而,在给予LHRH后的第二和第三小时,这些患者的血浆促性腺激素水平持续显著升高。这些研究并未解决LHRH给药后血浆LH和FSH水平长期升高是由于分泌增强、LHRH代谢清除率降低和/或促性腺激素所致,还是两者兼而有之的问题。来自本研究和先前研究的证据表明,这些患者中的一些人可能存在下丘脑和垂体分泌功能的缺陷。